A highly pathogenic human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently recognized in Wuhan, China, as the cause of the coronavirus disease 2019 (COVID-19) outbreak which has spread rapidly from China to other countries in the world, causing a pandemic with alarming morbidity and mortality. The emerging epidemiological data about COVID-19 patients suggest an association between cardiovascular diseases (CVD) and SARS-CoV-2 infection, in term of clinical features at hospital admission and prognosis for disease severity. The aim of our review is to describe the cardiological features of COVID-19 patients at admission, the acute cardiac presentation, the clinical outcome for patients with underlying CVD and the pharmacological implications for disease management.
【저자키워드】 cardiovascular diseases, Coronavirus disease 2019 (COVID-19), Cardiac biomarkers, myocardial injury, Arrhythmias, angiotensin-converting enzyme inhibitor, 【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, coronavirus, pandemic, Prognosis, SARS-COV-2 infection, disease severity, cardiovascular disease, Clinical outcome, Spread, China, outbreak, management, Patient, Hospital admission, morbidity and mortality, epidemiological data, disease, Admission, clinical feature, association, COVID-19 patient, CVD, acute respiratory syndrome, highly pathogenic, pharmacological, implication, country, feature, Wuhan, China, cardiological, 【제목키워드】 COVID-19, clinical,